Search Results - "Massimiliano, Salati"

Noncoding RNA in Cholangiocarcinoma by Salati, Massimiliano, Braconi, Chiara

“…Cholangiocarcinomas (CCAs) are tumors with a dismal prognosis. Early diagnosis is a key challenge because of the lack of specific symptoms, and the curability…”
Get more information

MicroRNAs (miRNAs) and Long Non-Coding RNAs (lncRNAs) as New Tools for Cancer Therapy: First Steps from Bench to Bedside by Ratti, Margherita, Lampis, Andrea, Ghidini, Michele, Salati, Massimiliano, Mirchev, Milko B., Valeri, Nicola, Hahne, Jens C.

“…Non-coding RNAs represent a significant proportion of the human genome. After having been considered as ‘junk’ for a long time, non-coding RNAs are now well…”
Get full text

Can IDO activity predict primary resistance to anti-PD-1 treatment in NSCLC? by Botticelli, Andrea, Cerbelli, Bruna, Lionetto, Luana, Zizzari, Ilaria, Salati, Massimiliano, Pisano, Annalinda, Federica, Mazzuca, Simmaco, Maurizio, Nuti, Marianna, Marchetti, Paolo

“…Immune checkpoint inhibitors have revolutionized the treatment paradigm of highly lethal malignancies like advanced non-small cell lung cancer (NSCLC),…”
Get full text

Medical treatment for cholangiocarcinoma by Adeva, Jorge, Sangro, Bruno, Salati, Maximiliano, Edeline, Julien, La Casta, Adelaida, Bittoni, Alessandro, Berardi, Rosanna, Bruix, Jordi, Valle, Juan W

“…Most of the patients with cholangiocarcinoma (CCA) present with advanced (inoperable or metastatic) disease, and relapse rates are high in those undergoing…”
Get full text

A nomogram to predict survival in non-small cell lung cancer patients treated with nivolumab by Botticelli, Andrea, Salati, Massimiliano, Di Pietro, Francesca Romana, Strigari, Lidia, Cerbelli, Bruna, Zizzari, Ilaria Grazia, Giusti, Raffaele, Mazzotta, Marco, Mazzuca, Federica, Roberto, Michela, Vici, Patrizia, Pizzuti, Laura, Nuti, Marianna, Marchetti, Paolo

“…The advent of immune checkpoint inhibitors (ICIs) has considerably expanded the armamentarium against non-small cell lung cancer (NSCLC) contributing to…”
Get full text

Adjuvant chemotherapy in resected bile duct cancer: A systematic review and meta-analysis of randomized trials by Messina, Carlo, Merz, Valeria, Frisinghelli, Michela, Trentin, Chiara, Grego, Elisabetta, Veccia, Antonello, Salati, Massimiliano, Messina, Marco, Carnaghi, Carlo, Caffo, Orazio

“…•The role of adjuvant chemotherapy for biliary tract cancers is still unclear.•We performed a meta-analysis to assess benefit and risks of adjuvant…”
Get full text

The prognostic nutritional index predicts survival and response to first‐line chemotherapy in advanced biliary cancer by Salati, Massimiliano, Filippi, Roberto, Vivaldi, Caterina, Caputo, Francesco, Leone, Francesco, Salani, Francesca, Cerma, Krisida, Aglietta, Massimo, Fornaro, Lorenzo, Sperti, Elisa, Di Maio, Massimo, Ortega, Cinzia, Fenocchio, Elisabetta, Lombardi, Pasquale, Cagnazzo, Celeste, Depetris, Ilaria, Gelsomino, Fabio, Spallanzani, Andrea, Santini, Daniele, Silvestris, Nicola, Aprile, Giuseppe, Roviello, Giandomenico, Scartozzi, Mario, Cascinu, Stefano, Casadei‐Gardini, Andrea

“…Background An accurate risk‐stratification is key to optimize the benefit‐to‐risk ratio of palliative treatment in advanced biliary cancer. We aimed at…”
Get full text

Circulating Tumor DNA in Gastric Adenocarcinoma: Future Clinical Applications and Perspectives by Grizzi, Giulia, Salati, Massimiliano, Bonomi, Maria, Ratti, Margherita, Holladay, Lauren, De Grandis, Maria Caterina, Spada, Daniele, Baiocchi, Gian Luca, Ghidini, Michele

“…Gastric cancer (GC) is still one of the most aggressive cancers with a few targetable alterations and a dismal prognosis. A liquid biopsy allows for…”
Get full text

Clinical Significance of Molecular Subtypes in Western Advanced Gastric Cancer: A Real-World Multicenter Experience by Salati, Massimiliano, Ghidini, Michele, Paccagnella, Matteo, Reggiani Bonetti, Luca, Bocconi, Alessandro, Spallanzani, Andrea, Gelsomino, Fabio, Barbin, Francesca, Garrone, Ornella, Daniele, Bruno, Dominici, Massimo, Facciorusso, Antonio, Petrillo, Angelica

“…In recent years, the molecular subtyping of gastric cancer has led to the identification of novel clinically relevant biomarkers as well as promising…”
Get full text

Ascites and resistance to immune checkpoint inhibition in dMMR/MSI-H metastatic colorectal and gastric cancers by Fucà, Giovanni, Cohen, Romain, Lonardi, Sara, Shitara, Kohei, Elez, Maria Elena, Fakih, Marwan, Chao, Joseph, Klempner, Samuel J, Emmett, Matthew, Jayachandran, Priya, Bergamo, Francesca, García, Marc Díez, Mazzoli, Giacomo, Provenzano, Leonardo, Colle, Raphael, Svrcek, Magali, Ambrosini, Margherita, Randon, Giovanni, Shah, Aakash Tushar, Salati, Massimiliano, Fenocchio, Elisabetta, Salvatore, Lisa, Chida, Keigo, Kawazoe, Akihito, Conca, Veronica, Curigliano, Giuseppe, Corti, Francesca, Cremolini, Chiara, Overman, Michael, Andre, Thierry, Pietrantonio, Filippo

“…BackgroundDespite unprecedented benefit from immune checkpoint inhibitors (ICIs) in patients with mismatch repair deficient (dMMR)/microsatellite instability…”
Get full text

Bone Metastases from Intrahepatic Cholangiocarcinoma Confer Worse Prognosis by Garajová, Ingrid, Gelsomino, Fabio, Salati, Massimiliano, Leonardi, Francesco, De Lorenzo, Stefania, Granito, Alessandro, Tovoli, Francesco

“…Metastatic intrahepatic cholangiocarcinoma still has a dismal prognosis. The aim of our study was to investigate the prognostic role of bone metastases in…”
Get full text

Integrated Genomics Identifies miR-181/TFAM Pathway as a Critical Driver of Drug Resistance in Melanoma by Barbato, Anna, Iuliano, Antonella, Volpe, Mariagrazia, D'Alterio, Romina, Brillante, Simona, Massa, Filomena, De Cegli, Rossella, Carrella, Sabrina, Salati, Massimiliano, Russo, Annapina, Russo, Giulia, Riccardo, Sara, Cacchiarelli, Davide, Capone, Mariaelena, Madonna, Gabriele, Ascierto, Paolo A, Franco, Brunella, Indrieri, Alessia, Carotenuto, Pietro

“…MicroRNAs (miRNAs) are attractive therapeutic targets and promising candidates as molecular biomarkers for various therapy-resistant tumors. However, the…”
Get full text

Successes and failures of angiogenesis blockade in gastric and gastro-esophageal junction adenocarcinoma by Salati, Massimiliano, Caputo, Francesco, Bocconi, Alessandro, Cerri, Sara, Baldessari, Cinzia, Piacentini, Federico, Dominici, Massimo, Gelsomino, Fabio

“…Gastric and gastro-esophageal junction adenocarcinoma (GEA) remains a considerable major public health problem worldwide, being the fifth most common cancer…”
Get full text

A phase II/III randomized clinical trial of CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative chemotherapy versus immediate resection in patIents with resecTable BiliarY Tract Cancers (BTC) at high risk for recurrence: PURITY study by Niger, Monica, Nichetti, Federico, Fornaro, Lorenzo, Pircher, Chiara, Morano, Federica, Palermo, Federica, Rimassa, Lorenza, Pressiani, Tiziana, Berardi, Rossana, Gardini, Andrea Casadei, Sperti, Elisa, Salvatore, Lisa, Melisi, Davide, Bergamo, Francesca, Siena, Salvatore, Mosconi, Stefania, Longarini, Raffaella, Arcangeli, Giuseppina, Corallo, Salvatore, Delliponti, Laura, Tamberi, Stefano, Fea, Elena, Brandi, Giovanni, Rapposelli, Ilario Giovanni, Salati, Massimiliano, Baili, Paolo, Miceli, Rosalba, Ljevar, Silva, Cavallo, Ilaria, Sottotetti, Elisa, Martinetti, Antonia, Busset, Michele Droz Dit, Sposito, Carlo, Di Bartolomeo, Maria, Pietrantonio, Filippo, de Braud, Filippo, Mazzaferro, Vincenzo

“…Biliary tract cancers (BTCs) are rare and lethal cancers, with a 5-year survival inferior to 20%(1-3). The only potential curative treatment is surgical…”
Get full text

The quality of palliative sedation in end-stage disease: audit from a department of oncology and haematology by Alessia, Saviola, Matilde, Schipilliti Francesca, Chrystel, Isca, Massimiliano, Salati, Daniele, Dini, Claudia, Fiorani, Raffaella, Postiglione, Flavia, Cantile, Leonardo, Ferrara, Chiara, Carboni, Leonardo, Potenza, Massimo, Dominici, Mario, Luppi, Giuseppe, Longo

“…  Purpose Palliative sedation (PS) plays a critical role to give suffering relief from refractory symptoms at the end of life. Our audit aimed to assess and…”
Get full text

Micro-RNA in Cholangiocarcinoma: Implications for Diagnosis, Prognosis, and Therapy by Barbato, Anna, Piscopo, Fabiola, Salati, Massimiliano, Reggiani-Bonetti, Luca, Franco, Brunella, Carotenuto, Pietro

“…Bile-duct cancers (BDC) are a group of solid tumors arising from the biliary tree. Despite their classification as rare cancers, the incidence of BDC is…”
Get full text

Correction to: A phase II/III randomized clinical trial of CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative chemotherapy versus immediate resection in patIents with resecTable BiliarY tract cancers (BTC) at high risk for recurrence: PURITY study by Niger, Monica, Nichetti, Federico, Fornaro, Lorenzo, Pircher, Chiara, Morano, Federica, Palermo, Federica, Rimassa, Lorenza, Pressiani, Tiziana, Berardi, Rossana, Gardini, Andrea Casadei, Sperti, Elisa, Salvatore, Lisa, Melisi, Davide, Bergamo, Francesca, Siena, Salvatore, Mosconi, Stefania, Longarini, Rafaella, Arcangeli, Giuseppina, Corallo, Salvatore, Delliponti, Laura, Tamberi, Stefano, Fea, Elena, Brandi, Giovanni, Rapposelli, Ilario Giovanni, Salati, Massimiliano, Baili, Paolo, Miceli, Rosalba, Ljevar, Silva, Cavallo, Ilaria, Sottotetti, Elisa, Martinetti, Antonia, Busset, Michele Droz Dit, Sposito, Carlo, Di Bartolomeo, Maria, Pietrantonio, Filippo, de Braud, Filippo, Mazzaferro, Vincenzo

Get full text

Irinotecan-based chemotherapy in extrapulmonary neuroendocrine carcinomas: survival and safety data from a multicentric Italian experience by Bardasi, Camilla, Spallanzani, Andrea, Benatti, Stefania, Spada, Francesca, Laffi, Alice, Antonuzzo, Lorenzo, Lavacchi, Daniele, Marconcini, Riccardo, Ferrari, Marco, Rimini, Margherita, Caputo, Francesco, Santini, Chiara, Cerma, Krisida, Casadei-Gardini, Andrea, Andrikou, Kalliopi, Salati, Massimiliano, Bertolini, Federica, Fontana, Annalisa, Dominici, Massimo, Luppi, Gabriele, Gelsomino, Fabio

“…Purpose Neuroendocrine carcinomas (NECs) are a rare subgroup of neuroendocrine neoplasms that occasionally originate from gastro-entero-pancreatic (GEP) tract…”
Get full text

Second-Line Chemotherapy for Intrahepatic Cholangiocarcinomas: What Is the Real Gain? by Garajová, Ingrid, Gelsomino, Fabio, Salati, Massimiliano, Mingozzi, Anna, Peroni, Marianna, De Lorenzo, Stefania, Granito, Alessandro, Tovoli, Francesco, Leonardi, Francesco

“…The presence of actionable alterations in advanced biliary tract cancer patients opened new therapeutic possibilities for second-line treatments. However, for…”
Get full text

Spontaneous Regression of an Inflammatory Myofibroblastic Tumor: A Case Report and a Review of the Literature by Medici, Bianca, Caffari, Eugenia, Salati, Massimiliano, Spallanzani, Andrea, Garajova, Ingrid, Piacentini, Federico, Dominici, Massimo, Gelsomino, Fabio

“…Spontaneous tumor regression is the volumetric reduction or complete disappearance of a primary tumor or metastatic sites (single or multiple) without the…”
Get full text